Outcomes4Me Secures $21M in Funding Learn more >>

/ Press

Get to know us better and help spread the word.

Our purpose is to improve outcomes for everyone by empowering cancer patients and democratizing healthcare. Please contact us with any press requests or inquiries.

Featured Coverage

Outcomes4Me named to TIME’s list of the Best Inventions of 2025

After experiencing a cancer scare, former Novartis executive Maya R. Said saw firsthand how nebulous...

Outcomes4Me partners with Labcorp and NBCUniversal on cancer care

While it’s impossible to quantify the impact of medical innovation on the world of cancer...

Health Tech: Maya Said On How Outcomes4Me’s Technology Can Make An Important Impact On Our Overall Wellness

You need to be very, very clear on the compass of your company. What value...

In the News

:: Fierce Pharma

Outcomes4Me Founder and CEO Maya Said honored on the Fierce 50 2026 list

Today, Outcomes4Me has grown into a comprehensive online resource that offers cancer care guidance “for every step...

Outcomes4Me is a 2026 Prix Galien USA nominee

Outcomes4Me is nominated for a 2026 Prix Galien USA award in the “Best Startup” category.

Outcomes4Me is on the 2026 Inc. 5000 list of fastest-growing companies

For the second year in a row, Outcomes4Me is recognized on the Inc. 5000.

:: Pfizer’s Science Will Win Podcast

The Pace of Science: AI in Cancer Care

Outcomes4Me Founder and CEO Maya Said is featured on the Pfizer Science Will Win podcast.

Real-World Biomarker Testing in HR+/HER2- Metastatic Breast Cancer

Outcomes4Me’s research study featured as a poster session at the Miami Breast Conference now published...

Outcomes4Me is #13 on the 2026 Inc. Regionals list

Outcomes4Me is #13 on the 2026 Inc. Regionals list

:: Cancer Today

A Digital Ally

Outcomes4Me Founder and CEO Maya Said speaks with Cancer Today about AI tools in cancer...

:: Inc. Magazine

Maya Said named to 2026 Inc. Female Founders 500

Outcomes4Me Founder and CEO Maya Said named to the 2026 Inc. Female Founders 500

Press Releases

Outcomes4Me Acquires Geno.Me and Realyze Intelligence, Names UPMC Hillman Cancer Center CIO as Strategic Advisor, to Expedite AI-driven Cancer Care and Clinical Trial Access

BOSTON–May 21, 2026– Outcomes4Me Inc., the leading direct-to-patient health technology company leveraging AI to revolutionize...

May 21, 2026

Outcomes4Me Named to TIME’s List of The Best Inventions of 2025

BOSTON–OCTOBER 9, 2025 –Today, Outcomes4Me announced it has been named to TIME’s Best Inventions of...

October 09, 2025

Outcomes4Me Acquires Germany’s Mika Health App to Accelerate AI-Driven Patient Empowerment Globally

Mika’s cancer app is a certified medical device clinically proven to help cancer patients cope...

June 12, 2025

Outcomes4Me Secures $21M in Funding to Accelerate AI-Driven Innovation and Drive Global Expansion to Transform Cancer Care

BOSTON–May 29, 2025– Outcomes4Me Inc., the developer of the leading direct-to-patient, AI-driven platform transforming the...

May 29, 2025

If you’re a member of the press,
please reach out.